UBS raised the firm’s price target on Calumet Specialty Products to $18.50 from $17.50 on Friday, while keeping a Neutral rating on the shares. The firm adjusted its Q2 EBITDA estimate to $60.7M vs. Street of $62M and its prior estimate of $52M. UBS expects both SPS as well as Montana renewables to show improvement quarter-over-quarter. As a result, it expects EBITDA to be up $38M quarter-over-quarter.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLMT: